IL6 and chronic kidney disease: This was corroborated in a 2015 case study of multiple biomarker levels in 543 ESRD patients, confirming that IL-6 is a strong independent predictor of clinical outcome in patients with CKD (Zuidema and Dellsperger, 2012; Arcari et al., 2021)